合計 50 件の最近のインサイダー取引記録が記録されています SAB Biotherapeutics, Inc. (SABS), 内訳は 38 件の買い および 8 件の売り. インサイダー買い総額は $151.56M インサイダー売り総額は $180.65K.
最近活動のある主要インサイダーには Kropotova Alexandra, Reich Samuel J, Sullivan Eddie Joe. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — SABS
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2026-03-24 |
Kropotova Alexandra |
Chief Medical Officer |
RSU 源泉徴収 |
988 |
- |
- |
43,296 |
| 2026-02-03 |
Reich Samuel J |
CEO |
RSU 付与（制限付株式） |
4,800,000 |
$4.45 |
$21.36M |
4,800,000 |
| 2026-02-03 |
Kropotova Alexandra |
Chief Medical Officer |
RSU 付与（制限付株式） |
2,400,000 |
$4.45 |
$10.68M |
2,400,000 |
| 2026-02-03 |
Sullivan Eddie Joe |
President |
RSU 付与（制限付株式） |
3,000,000 |
$4.45 |
$13.35M |
3,000,000 |
| 2026-02-03 |
Bausch Christoph Lawrence |
Chief Operating Officer |
RSU 付与（制限付株式） |
1,800,000 |
$4.45 |
$8.01M |
1,800,000 |
| 2026-02-03 |
To Lucy |
See Remarks |
RSU 付与（制限付株式） |
2,400,000 |
$4.45 |
$10.68M |
2,400,000 |
| 2026-01-05 |
Zaccardelli David |
Officer |
不明 |
- |
- |
- |
- |
| 2026-01-05 |
Zaccardelli David |
Director |
RSU 付与（制限付株式） |
240,000 |
$3.74 |
$897.6K |
240,000 |
| 2026-01-05 |
Jain Rita |
Officer |
不明 |
- |
- |
- |
- |
| 2026-01-05 |
Jain Rita |
Director |
RSU 付与（制限付株式） |
240,000 |
$3.74 |
$897.6K |
240,000 |
| 2025-12-16 |
Skyler Jay S |
Director |
RSU 付与（制限付株式） |
150,000 |
$3.99 |
$598.5K |
150,000 |
| 2025-12-16 |
Lucera Erick |
Director |
RSU 付与（制限付株式） |
150,000 |
$3.99 |
$598.5K |
150,000 |
| 2025-12-16 |
Polvino William James |
Director |
RSU 付与（制限付株式） |
150,000 |
$3.99 |
$598.5K |
150,000 |
| 2025-12-16 |
Giberson Scott |
Director |
RSU 付与（制限付株式） |
150,000 |
$3.99 |
$598.5K |
150,000 |
| 2025-12-16 |
Ellias Helen K. |
Director |
RSU 付与（制限付株式） |
150,000 |
$3.99 |
$598.5K |
150,000 |
| 2025-12-16 |
Link David |
Director |
RSU 付与（制限付株式） |
150,000 |
$3.99 |
$598.5K |
150,000 |
| 2025-12-11 |
Kropotova Alexandra |
Chief Medical Officer |
RSU 源泉徴収 |
988 |
- |
- |
44,284 |
| 2025-09-29 |
Sessa Capital (master), L.p. |
Director |
オプション行使（売却） |
17,400 |
$1.75 |
$30.45K |
211,100 |
| 2025-09-29 |
Moin Andrew |
Director |
オプション行使（売却） |
17,400 |
$1.75 |
$30.45K |
211,100 |
| 2025-09-19 |
Kropotova Alexandra |
Chief Medical Officer |
RSU 源泉徴収 |
1,977 |
- |
- |
45,272 |
| 2025-08-26 |
Reich Samuel J |
CEO & Executive Chairman |
RSU 付与（制限付株式） |
4,800,000 |
$2.17 |
$10.42M |
4,800,000 |
| 2025-08-26 |
Kropotova Alexandra |
Chief Medical Officer |
RSU 付与（制限付株式） |
2,400,000 |
$2.17 |
$5.21M |
2,400,000 |
| 2025-08-26 |
Sullivan Eddie Joe |
President |
RSU 付与（制限付株式） |
3,000,000 |
$2.17 |
$6.51M |
3,000,000 |
| 2025-08-26 |
Bausch Christoph Lawrence |
Chief Operating Officer |
RSU 付与（制限付株式） |
600,000 |
$2.17 |
$1.3M |
600,000 |
| 2025-08-26 |
To Lucy |
See Remarks |
RSU 付与（制限付株式） |
1,200,000 |
$2.17 |
$2.6M |
1,200,000 |
| 2025-07-22 |
Sessa Capital (master), L.p. |
Director |
RSU 付与（制限付株式） |
114,250 |
$218.75 |
$24.99M |
114,250 |
| 2025-07-22 |
Moin Andrew |
Director |
RSU 付与（制限付株式） |
114,250 |
$218.75 |
$24.99M |
114,250 |
| 2025-03-27 |
Kropotova Alexandra |
Chief Medical Officer |
RSU 源泉徴収 |
1,179 |
- |
- |
47,249 |
| 2024-12-18 |
Kropotova Alexandra |
Chief Medical Officer |
RSU 源泉徴収 |
9,072 |
- |
- |
48,428 |
| 2024-11-01 |
Ellias Helen K. |
Director |
RSU 付与（制限付株式） |
20,000 |
$3.88 |
$77.6K |
20,000 |
| 2024-08-12 |
To Lucy |
See Remarks |
RSU 付与（制限付株式） |
125,000 |
$2.35 |
$293.75K |
125,000 |
| 2024-07-26 |
To Lucy |
Officer |
不明 |
- |
- |
- |
- |
| 2024-07-15 |
Hamilton Christine E |
Director |
RSU 付与（制限付株式） |
2,326 |
$2.90 |
$6.75K |
2,326 |
| 2024-07-15 |
Skyler Jay S |
Director |
RSU 付与（制限付株式） |
20,000 |
$2.90 |
$58K |
20,000 |
| 2024-07-15 |
Reich Samuel J |
CEO & Executive Chairman |
RSU 付与（制限付株式） |
35,700 |
$2.90 |
$103.53K |
35,700 |
| 2024-07-15 |
Spragens Jeffrey G |
Director |
RSU 付与（制限付株式） |
20,000 |
$2.90 |
$58K |
20,000 |
| 2024-07-15 |
Lucera Erick |
Director |
RSU 付与（制限付株式） |
20,000 |
$2.90 |
$58K |
20,000 |
| 2024-07-15 |
Polvino William James |
Director |
RSU 付与（制限付株式） |
13,958 |
$2.90 |
$40.48K |
13,958 |
| 2024-07-15 |
Link David Charles |
Director |
RSU 付与（制限付株式） |
9,305 |
$2.90 |
$26.98K |
9,305 |
| 2024-07-15 |
Sullivan Eddie Joe |
President |
RSU 付与（制限付株式） |
4,447 |
$2.90 |
$12.9K |
4,447 |
| 2024-07-15 |
Giberson Scott |
Director |
RSU 付与（制限付株式） |
20,000 |
$2.90 |
$58K |
20,000 |
| 2024-06-04 |
Conley Mark William |
See Remarks |
処分 |
25,000 |
$4.79 |
$119.75K |
- |
| 2024-05-03 |
Skyler Jay S |
Officer |
不明 |
- |
- |
- |
- |
| 2024-02-21 |
Reich Samuel J |
CEO & Executive Chairman |
RSU 付与（制限付株式） |
434,000 |
$5.17 |
$2.24M |
434,000 |
| 2024-02-21 |
Kropotova Alexandra |
Chief Medical Officer |
RSU 付与（制限付株式） |
140,000 |
$5.17 |
$723.8K |
140,000 |
| 2024-02-21 |
Sullivan Eddie Joe |
President |
RSU 付与（制限付株式） |
190,000 |
$5.17 |
$982.3K |
190,000 |
| 2024-02-21 |
Bausch Christoph Lawrence |
Chief Operating Officer |
RSU 付与（制限付株式） |
140,000 |
$5.17 |
$723.8K |
140,000 |
| 2024-02-21 |
King Michael |
Chief Financial Officer |
RSU 付与（制限付株式） |
115,000 |
$5.17 |
$594.55K |
115,000 |
| 2023-12-07 |
Sullivan Eddie Joe |
Chief Executive Officer |
情報に基づく買い |
1,740 |
$0.88 |
$1.53K |
5,232,304 |
| 2023-11-30 |
King Michael |
Chief Financial Officer |
情報に基づく買い |
5,000 |
$0.90 |
$4.5K |
5,000 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
